An interventional study of SINTYA in Borderline Personality Disorder, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to participants aged 16 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Borderline Personality Disorder with a site in France — 12 open to participants now, 13 under way, none of them phase 3. Borderline Personality Disorder · France.
Among the 32 studies in Borderline Personality Disorder with a site in France, this one is the 12th largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2023, is one of 20 with no phase, and was the 23rd registered.
279 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.
Browse Borderline Personality Disorder studies →12 of the 32 studies in Borderline Personality Disorder with a site in France are open now. Recruiting first, the newest first:
University Hospital, Montpellier · Sites in France
Ages 18–45 · Healthy volunteers
University Hospital, Strasbourg, France · Sites in France
Ages 12–18
University Hospital, Strasbourg, France · Sites in France
Ages 18–60 · Healthy volunteers
AddiPsy · Sites in France
Ages 18+
Etablissement Public de la Sante Mentale de la Somme · Sites in France
Ages 12–17 · Women only · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 49 Borderline Personality Disorder studies recruiting now, 18 (37%) set no upper age limit and 30 (61%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.
This study: 16 Years to 25 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 3 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 74 is close to the median of 70 across 222 interventional studies indexed under Borderline Personality Disorder.
Median enrollment 72 across the 24 interventional studies, 99 across the 8 observational. Of the 13 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 32 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 595 studies on the registry; 87 are open to participants now.
Centre Hospitalier Universitaire de Nīmes has 2 studies filed under Borderline Personality Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Borderline Personality Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07540429Etablissement Public de la Sante Mentale de la SommeADOLESCENTS IMAGING USING fMRI: Feasibility Study | 2027-06-08 |
| NCT07794332University Hospital, Strasbourg, FranceSymptom Assessment in Adolescents Placed on Child Welfare | 2027-09-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Borderline Personality Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: SINTYA
10-week psychotherapy program consisting of a weekly 1h30 hour group therapy session plus 1 hour individual therapy session
Variation in explicit impulsivity between groups
UPPS-S (Impulsive Behavior Scale Short version score)
Time frame: Baseline
Variation in explicit impulsivity between groups
UPPS-S (Impulsive Behavior Scale Short version score)
Time frame: Month 4
Variation in explicit impulsivity between groups
UPPS-S (Impulsive Behavior Scale Short version score)
Time frame: Month 7
Variation in impulsiveness between groups
Barratt Impulsiveness Scale (BIS-11) (score out of 120)
Time frame: Baseline
Variation in impulsiveness between groups
Barratt Impulsiveness Scale (BIS-11) (score out of 120)
Time frame: Month 4
Variation in impulsiveness between groups
Barratt Impulsiveness Scale (BIS-11) (score out of 120)
Time frame: Month 7
BPD severity level between groups
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36)
Time frame: Baseline
BPD severity level between groups
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36)
Time frame: Month 4
BPD severity level between groups
Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) (score out of 36)
Time frame: Month 7
Emotional regulation capacities between groups
Difficulties in Emotion Regulation Scale (DERS-18)
Time frame: Baseline
Emotional regulation capacities between groups
Difficulties in Emotion Regulation Scale (DERS-18)
Time frame: Month 4
Emotional regulation capacities between groups
Difficulties in Emotion Regulation Scale (DERS-18)
Time frame: Month 7
Dissociative symptoms between groups
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder
Time frame: Baseline
Dissociative symptoms between groups
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder
Time frame: Month 4
Dissociative symptoms between groups
Dissociative Experiences Scale (DES): a score of 25 or higher is predictive of dissociative disorder
Time frame: Month 7
Aggression between groups
Aggression Questionnaire (AQ-12)
Time frame: Baseline
Aggression between groups
Aggression Questionnaire (AQ-12)
Time frame: Month 4
Aggression between groups
Aggression Questionnaire (AQ-12)
Time frame: Month 7
Ruminations between groups
Rumination Reflection Questionnaire (RRQ)
Time frame: Baseline
Ruminations between groups
Rumination Reflection Questionnaire (RRQ)
Time frame: Month 4
Ruminations between groups
Rumination Reflection Questionnaire (RRQ)
Time frame: Month 7
Number of self-destructive behaviors between groups
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview
Time frame: Baseline
Number of self-destructive behaviors between groups
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview
Time frame: Month 4
Number of self-destructive behaviors between groups
Number of self-destructive/self-mutilatory/parasuicidal acts reported by the patient in a clinical interview
Time frame: Month 7
Number of impulsive behaviors between groups
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related)
Time frame: Baseline
Number of impulsive behaviors between groups
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related)
Time frame: Month 4
Number of impulsive behaviors between groups
Number of impulsive behaviors (food, motor vehicles, sexual, drug-related)
Time frame: Month 7
Level of suicide risk between groups
Columbia-Suicide Severity Rating Scale (C-SSRS)
Time frame: Baseline
Level of suicide risk between groups
Columbia-Suicide Severity Rating Scale (C-SSRS)
Time frame: Month 4
Level of suicide risk between groups
Columbia-Suicide Severity Rating Scale (C-SSRS)
Time frame: Month 7
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Information taken from patient medical file
Time frame: 12 Months prior to inclusion
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Information taken from patient medical file
Time frame: Baseline
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Information taken from patient medical file
Time frame: Month 4
Number of psychiatric hospitalizations and emergency visits for psychiatric reasons between groups
Information taken from patient medical file
Time frame: Month 7
Psychosocial functioning between groups
Functional Assessment Staging Tool (FAST)
Time frame: Baseline
Psychosocial functioning between groups
Functional Assessment Staging Tool (FAST)
Time frame: Month 4
Psychosocial functioning between groups
Functional Assessment Staging Tool (FAST)
Time frame: Month 7
Implicit impulsivity between groups
Continuous Performance Test (CPT)
Time frame: Baseline
Implicit impulsivity between groups
Continuous Performance Test (CPT)
Time frame: Month 4
Implicit impulsivity between groups
Continuous Performance Test (CPT)
Time frame: Month 7
Neurocognitive evaluation of implicit impulsivity between groups
Emotional Stroop (SE) customized to the study
Time frame: Baseline
Neurocognitive evaluation of implicit impulsivity between groups
Emotional Stroop (SE) customized to the study
Time frame: Month 4
Neurocognitive evaluation of implicit impulsivity between groups
Emotional Stroop (SE) customized to the study
Time frame: Month 7
Risk taking between groups
Balloon Analogue Risk Task (BART)
Time frame: Baseline
Risk taking between groups
Balloon Analogue Risk Task (BART)
Time frame: Month 4
Risk taking between groups
Balloon Analogue Risk Task (BART)
Time frame: Month 7
Decision making under risk conditions between groups
Game Dice Task (GDT)
Time frame: Baseline
Decision making under risk conditions between groups
Game Dice Task (GDT)
Time frame: Month 4
Decision making under risk conditions between groups
Game Dice Task (GDT)
Time frame: Month 7
Plan to share: Yes — All IPD that underlie results in a publication
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Upon publication
Access criteria: The IPD will be made available to other researchers upon reasonable request to the corresponding author
No publications or documents are linked to this record.
Ran from Nov 2023 to primary completion in Sep 2025, 22 months.
Of 106 non-industry interventional studies with no phase under Borderline Personality Disorder, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 54. This study's 22 months is below that.
Counting every sponsor, half of 108 studies reached it within 35 months; a quarter within 24 and three quarters within 53.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Sep 2026 → Sep 2025 and completion Sep 2026 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Borderline Personality Disorder →
Centre Hospitalier Universitaire de Nīmes →